9th International Caparica Conference on Analytical Proteomics 2024

23rd to 27th June 2024 | Caparica | Portugal

Poster Contributions

Anja Dollinger

LMU Munich; TUM (Germany)

Modeling mycobacterial metabolism in tuberculosis therapy based on dynamic intact protein analysis by mass spectrometry.

Francisco Calderón Celis

University of Oviedo (Spain)

Absolute quantification of protein phosphorylation with ICP-MS

Carolina Silva

National Health Institute Dr. Ricardo Jorge (Portugal)

Statistical Analysis of Longitudinal Red Blood Cells Omics Data

Hicham Benabdelkamel

King Saud University, Riyadh (Saudi Arabia)

Multiple-Reaction Monitoring–Mass Spectrometric Immunoassay Analysis of Parathyroid Hormone Variants with Vitamin D Deficiency in Patients with Diabetes Mellitus

Filipa Martins

Proteomics Lab, Department of Human Genetics, National Institute of Health Dr. Ricardo Jorge, Lisboa (Portugal)

Red Blood Cells Metabolomic study in patients with Obstructive Sleep Apnea to uncover candidate biomarkers

Sofia Neves

Instituto Nacional de Saúde Dr. Ricardo Jorge (Portugal)

Occupational secondhand smoke exposure: a comparative shotgun proteomics study

Roberto Benoni

IRBM SPA (Italy)

Proteomic approaches for target identification of a monoclonal antibody

Jaroslava Friedecka

Laboratory of Growth Regulators,Palacký University & Institute of Experimental Botany AS CR (Czech Republic)

Proteomics and peptidomics of patients with inflammatory bowel disease

Kiyokazu Kakugawa

Laboratory for inflammatory Immune Metabolism, RIKEN-IMS (Japan)

Establishment of Inducible Disruption of Bioactive Lipid Receptors on Neutrophils Using an In Vivo Degron System.

Majia Corey

La Jolla Institute for Immunology (USA)

Development of multi-functional assay to monitor neutrophil activation and apoptosis.

Loutje van der Sman

La Jolla Institute for Immunology (USA)

A High Throughput Screen for G-Protein Coupled Receptors Involved Anti-Inflammatory Lipid Signaling

Amaury Lachaud

Biognosys AG (Switzerland)

Mass spectrometry-based pharmacokinetic analysis of OMO-103 therapeutic miniprotein in patient tissues with advanced solid tumors

Deborah Penque

National institute of Health Dr Ricardo Jorge (Portugal)

Exploring the Interplay Between Covid-19 Vaccination, Red Blood Cells, and Immune Function

Mujia Li

Institute of Clinical Pathology, Oncoescape (Germany)

Secretome and Degradome Analysis Reveal Effects of Kallikrein-related Peptidase 6 on ECM Arrangement and Immune Recognition in PDAC

Johana Thiery

Institute for Surgical Patholgy Freiburg (Germany)

Insights from Proteomic Analysis in Crohn’s Disease

Ruth Fiestas Cueto

Institute for Surgical Patholgy Freiburg, ProPath Research Training Group (Germany)

The proteomic and immunopeptidomic landscape of non-small cell lung cancer

Participation Only

XXX, MSc

Affiliation: